Therma Bright (TSE:THRM) has released an update.
Therma Bright Inc. is enhancing its stake in InStatin as part of a strategic partnership with InVixa to develop innovative respiratory solutions, including a promising statin inhalant for asthma and COPD. This collaboration aims to leverage a growing market opportunity and bring effective treatments to individuals with acute lung diseases.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
